Corteva Strategy and Business Model

Executive Overview

Corteva is a global agriculture-input company that became an independent public company in 2019 after the separation of DowDuPont. Headquartered in Indianapolis, Indiana, Corteva operates in two core businesses: seeds and crop protection. Its seed franchise is anchored by the Pioneer and Brevant brands, while its crop protection portfolio spans herbicides, insecticides, fungicides, biologicals, and related agronomic solutions. Company materials in 2025 describe a commercial reach of more than 120 countries. As of FY2024, Corteva generated roughly $16.9 billion in net sales.

Strategically, Corteva is trying to combine the repeat-purchase economics of seasonal farm inputs with a more innovation-heavy mix: proprietary germplasm and traits in seeds, differentiated active ingredients and biological solutions in crop protection, and local agronomic support that helps growers improve yields and manage resistance. That matters because agriculture inputs are not purely commodity products. Performance in the field, regulatory approvals, stewardship, channel relationships, and supply-chain reliability all affect pricing power and loyalty. Corteva therefore sits at the intersection of industrial operations, life-sciences R&D, and seasonal distribution execution, with North American row crops remaining especially important to the company’s economics.

Corteva at a Glance

Logo
Common name	Corteva
Full legal name	Corteva, Inc.
Headquarters	Indianapolis, Indiana, United States
Ownership	Public company
Ticker	CTVA
Exchange	NYSE - New York Stock Exchange
Market Cap	$52.94B
Revenue (FY2024)	$16.92B
Founding / major historical milestones	Independent since June 2019 following the DowDuPont separation; roots include Pioneer Hi-Bred and Dow AgroSciences
Industry or industries	Agricultural inputs; seeds, traits, crop protection, biologicals, and digital agriculture
Key products or services	Corn and soybean seed, trait technologies, herbicides, insecticides, fungicides, biologicals, and agronomic/digital tools
Geographic footprint	Global; company materials in 2025 describe sales in more than 120 countries
Business segments as officially reported	Seed; Crop Protection
Company website	https://www.corteva.com/

1. What Is the Strategy of Corteva?

Corteva’s public disclosures in FY2024 and 2025 describe a strategy built around innovation-led growth, customer intimacy with farmers, operational discipline, and disciplined capital allocation. Using the Playing to Win framework, the strategy can be framed as follows.

1. 1a. What is the winning aspiration of Corteva?

   Corteva’s winning aspiration is to be the leading pure-play agriculture company by helping farmers increase productivity and profitability while improving the sustainability of crop production. In practical terms, “winning” means growing faster than underlying acreage through a richer mix of proprietary seeds, traits, crop protection innovations, and biologicals; sustaining attractive margins and cash generation; and converting scientific innovation into products farmers are willing to repurchase each season.

2. 1b. Where does Corteva play?

   Corteva plays in global agricultural inputs, with a strong focus on seeds and traits for row crops and on crop protection across herbicides, insecticides, fungicides, and biologicals. It competes in major crop systems such as corn and soybeans, where its North American franchise is particularly important, while also serving Latin America, Europe, and other international markets. It reaches customers through a mix of direct-to-grower seed sales, retail channels, distributor networks, and trait licensing relationships.

3. 1c. How does Corteva plan to win?

   Corteva plans to win through differentiated product performance rather than by being the low-cost supplier. In seeds, that means better germplasm, higher-value trait packages, and strong local agronomic support. In crop protection, it means leaning on proprietary active ingredients, branded systems such as Enlist, and expanding biological solutions rather than relying mainly on undifferentiated off-patent chemistry. The company also uses channel architecture as a strategic tool: Pioneer emphasizes a premium, relationship-intensive model, while Brevant is positioned for retail channels.

4. 1d. What capabilities must Corteva have in place?

   The key capabilities are long-cycle R&D in breeding, genomics, trait development, chemistry, and biological discovery; regulatory and stewardship expertise; reliable seasonal seed production and crop protection manufacturing; local agronomy and grower-facing sales execution; and the data systems needed to manage product development, field performance, pricing, inventory, and demand planning. Integration capability also matters because recent acquisitions in biologicals need to be converted into scaled commercial platforms.

5. 1e. What management systems does Corteva require?

   Corteva requires management systems that can handle long innovation cycles and highly seasonal execution. That includes stage-gate portfolio management for R&D, regulatory compliance and stewardship systems for seeds and chemistry, global supply-and-demand planning, product profitability and pricing analytics, and capital allocation processes that balance reinvestment, bolt-on acquisitions, dividends, and buybacks. Because agriculture is exposed to weather, commodity prices, and channel inventory swings, the company also needs management routines that let it adjust production, pricing, and commercial focus quickly.

2. What Are the Current Strategic Initiatives of Corteva?

Across its FY2024 annual report, investor materials, and 2025 management commentary, Corteva has emphasized a set of concrete strategic initiatives rather than a broad conglomerate-style agenda. The main initiatives are the following.

• Drive premium seed growth through better germplasm and trait mix. Corteva continues to prioritize higher-value seed offerings, especially in corn and soybeans, where trait performance, yield stability, and resistance management matter most. The Enlist system remains strategically important because it combines seed traits with associated herbicide demand and can deepen customer retention.
• Expand the crop protection innovation mix. The company is working to lift the share of sales from newer, differentiated products rather than relying too heavily on mature chemistry. That supports pricing, mix, and longer-duration gross margins.
• Build biologicals into a scaled business. Following the additions of Stoller and Symborg in 2023, Corteva has been integrating biologicals more deeply into its product portfolio, R&D base, and commercial channels. Biologicals are attractive strategically because they can complement conventional chemistry and seed offerings rather than simply replace them.
• Improve productivity and execution. Management has consistently emphasized cost productivity, manufacturing and supply-chain reliability, and tighter working-capital execution. This matters in a seasonal industry where service failures can destroy value in a single planting or application window.
• Use digital tools to strengthen agronomy and customer relationships. Corteva’s digital capabilities, including farm-management and agronomic tools, appear aimed less at becoming a standalone software company and more at making the seed and crop protection franchise more effective.
• Allocate capital selectively. The company’s public posture has been to fund R&D and core operations first, pursue targeted capability-building deals second, and return excess cash to shareholders through dividends and repurchases.

3. What Is the Business Model of Corteva?

What customers actually buy

Corteva sells farm productivity inputs. Customers buy seed with specific genetic characteristics, trait packages that help manage pests and weeds, herbicides and other crop protection products, biologicals, and agronomic support. In some cases, customers are also buying a system rather than an individual product. Enlist is a good example: the value proposition combines crop genetics, herbicide tolerance, and compatible chemistry.

What portion of the model appears recurring or repeat-driven versus one-time

Corteva’s revenue is not recurring in the software sense, but it is highly repeat-driven. Farmers buy seed and crop protection products season after season, and strong field performance can create durable repurchase behavior. Trait licensing can create more contract-like revenue streams, and digital tools can add service revenue, but the core economics remain seasonal and agronomic rather than subscription-based.

How pricing power works

Pricing power depends on product differentiation, local performance, and switching costs. Better genetics, proprietary traits, and novel crop protection actives can support price realization. That said, pricing power is constrained by crop prices, farm income, generic competition in crop protection, and the bargaining position of large retail and distributor channels. In short, Corteva has pricing power in differentiated offerings, but not unlimited pricing power across the whole portfolio.

Why the business mix matters

Business mix is central to value creation. Premium seed products and newer crop protection innovations typically carry stronger margins than mature or more commoditized offerings. Biologicals can also improve mix if Corteva scales them effectively. Geography matters too: product economics differ by crop system, regulatory regime, and channel structure.

What drives gross margin, operating margin, and cash generation

Gross margin is driven by innovation mix, manufacturing and seed production yields, raw material costs, pricing discipline, and the balance between premium and mature products. Operating margin also reflects how much selling expense is required to maintain local agronomic coverage and how efficiently R&D and corporate costs are leveraged. Cash generation is heavily influenced by seasonal working-capital swings because the company must build inventory ahead of planting and application windows and then collect receivables as the season progresses.

Revenue model

The revenue model is mainly product sales, supplemented by licensing and some service or digital revenue. It is best described as a repeat seasonal input model with intellectual-property characteristics, not as a pure commodity model and not as a recurring-subscription model.

4. What Products and/or Services Does Corteva Sell?

Corteva reports two main business segments: Seed and Crop Protection.

• Seed. This segment includes germplasm and trait technologies sold under brands such as Pioneer and Brevant. The most important economic categories are row-crop seeds, especially corn and soybeans, with additional positions in other crop categories depending on geography.
• Crop Protection. This segment includes herbicides, insecticides, fungicides, seed-applied technologies, and biological products. Corteva’s strategy is to tilt the portfolio toward more differentiated and newer offerings rather than relying only on older post-patent chemistries.
• Biologicals. Biological products are increasingly important strategically. They include plant health, microbial, and related solutions that can complement seed and chemical programs.
• Digital and agronomic tools. Corteva also offers digital and agronomic support capabilities, including products associated with its Granular platform and other decision-support tools.

The offerings that appear most strategically important are premium corn and soybean seed, Enlist-related products, differentiated crop protection actives, and the expanding biologicals portfolio. Mature crop protection products still matter economically, but newer innovation platforms are more important for long-term growth and margin resilience.

5. What Are the Key Competitors or Peers of Corteva?

Corteva competes across both seeds and crop protection, so no single competitor is a perfect one-for-one comparison. The most relevant competitors and peers are the following.

In addition to these large players, Corteva also competes with regional seed companies, local chemical formulators, and independent biologicals firms. Competitive intensity differs sharply by product category: seed competition is often local and performance-based, while crop protection competition can be shaped by patent status, regulation, and channel economics.

6. What Is the Marketing Strategy of Corteva?

Corteva’s marketing strategy is much more field-led and agronomy-led than mass-media-led. This is a business where customer trust is built through field performance, local recommendations, trial data, and service reliability rather than broad consumer advertising.

In seeds, brand architecture is especially important. Pioneer functions as a premium brand supported by local agronomy, performance proof, and close grower relationships. Brevant serves a different marketing role by fitting better into retail distribution channels. In crop protection, marketing is typically tied to technical claims, stewardship, resistance management, crop-specific positioning, and distributor or retailer support programs.

Performance marketing in the consumer internet sense is not the core model here. Instead, Corteva appears to rely on a mix of product demonstration, field marketing, technical service, channel marketing, and local sales enablement. Marketing is therefore a supporting capability with real strategic value: it helps translate science and product claims into farmer adoption.

7. What Are the Key Customer Segments of Corteva?

Corteva serves several distinct customer groups, with economics concentrated in commercial agriculture rather than small-scale consumer channels.

• Large row-crop farmers. In North America especially, corn and soybean growers are central to the seed business and remain a major profit pool.
• Farmers in Latin America. Brazil, Argentina, and other Latin American markets are important for both seeds and crop protection and offer growth potential, though they can be more volatile.
• Agricultural retailers, cooperatives, and distributors. These intermediaries are critical in crop protection and in parts of the seed business, especially for retail-oriented brands.
• Independent seed companies and partners. Corteva also participates in trait licensing and related business relationships, where the customer is another seed company rather than the farmer directly.
• Specialty-crop growers. In crop protection, Corteva serves a broader set of crop systems beyond the row-crop heartland.

The company is diversified by crop and geography, but it is not equally exposed everywhere. North American row crops remain especially important to earnings quality, while international markets offer growth and portfolio diversification.

8. What Is the Sales Model of Corteva?

Corteva uses a multi-channel sales model tailored to product type and market structure.

• Direct seed sales. Pioneer has historically used a direct-to-grower model supported by local sales representatives and agronomic expertise. This creates customer intimacy and can support premium pricing.
• Retail-channel seed sales. Brevant is better aligned with retail and dealer channels, giving Corteva broader market coverage without forcing one route-to-market model onto every customer.
• Distributor-led crop protection sales. Crop protection products typically move through retailers, distributors, cooperatives, and wholesalers, with some direct account management depending on geography.
• Licensing and partnership revenue. Some trait and technology value is monetized through licensing and other business-to-business arrangements.

This channel structure affects growth and pricing in important ways. Direct relationships can improve insight and loyalty, but they are more expensive to maintain. Distributor-led models scale more efficiently but can reduce control over the end-customer relationship. For a company like Corteva, route-to-market design is therefore a genuine strategic lever, not just a commercial afterthought.

9. In What Geographies Does Corteva Operate?

Corteva operates globally, with especially important positions in North America, Latin America, Europe, and other international agricultural markets. Company materials in 2025 describe sales in more than 120 countries.

North America is particularly important because of the company’s strong row-crop seed franchise and the economic significance of corn and soybeans. Latin America is also strategically important, especially for crop protection and seed growth opportunities. Europe, the Middle East, and Africa are relevant for crop protection and selected seed categories, while Asia-Pacific broadens the customer base across additional crop systems and geographies.

Operationally, Corteva’s footprint includes global commercial offices, R&D sites, seed production and conditioning operations, and crop protection manufacturing and formulation facilities. Indianapolis is the corporate headquarters, and Johnston, Iowa remains an important seed and research hub through the Pioneer heritage. The company is geographically diversified, but its economics are still shaped disproportionately by a handful of large agricultural regions.

10. Who Are the Owners of Corteva?

As a public company, Corteva does not have a disclosed controlling shareholder. Based on public filings and the company’s 2025 proxy disclosures, ownership is broadly institutional, with large asset managers such as The Vanguard Group, BlackRock, and State Street among the significant shareholders. That ownership profile is typical for a large U.S. listed company and means governance is driven more by board oversight and institutional investor expectations than by a single strategic owner.

11. How Is Corteva Organized?

Corteva is organized around two official reportable segments: Seed and Crop Protection. That reporting structure is important because it reflects two distinct economic models: seeds combine biology, breeding, and local commercialization, while crop protection combines chemistry, regulatory approvals, manufacturing, and distributor-heavy sales channels.

In practice, the company also operates through geographic commercial organizations because farming systems, product registrations, planting cycles, and channel structures vary sharply by region. Brands such as Pioneer and Brevant add another layer of practical organization inside seeds, while biologicals and digital capabilities increasingly cut across traditional segment boundaries. Corporate functions such as R&D, finance, legal, regulatory, and supply chain provide shared capabilities across the enterprise.

12. How Does Corteva Operate?

Corteva’s day-to-day operations combine scientific development, industrial manufacturing, and seasonal commercial execution.

Seed operations

The seed business starts years before a sale is made. Corteva develops and tests germplasm, integrates traits, multiplies parent seed, produces commercial seed, conditions and packages it, and then delivers it through direct or channel-based routes to market ahead of planting season. Field testing, trait stewardship, seed quality, and logistics timing are critical because a missed season cannot easily be recovered.

Crop protection operations

Crop protection operations involve discovery or development of active ingredients and formulations, regulatory approvals, manufacturing or tolling, inventory planning, and distribution through agricultural channels. Performance depends on product efficacy, plant utilization, raw material sourcing, formulation quality, and the ability to position products correctly in local agronomic systems.

Operational complexity

Corteva also has to manage weather risk, commodity-price swings, pest resistance, global registrations, and channel inventory cycles. That makes operational resilience unusually important. A strong research pipeline is not enough; the company must also get the right products into the right geography at the right point in the crop cycle.

13. What Are the Growth Opportunities for Corteva?

The most plausible growth opportunities for Corteva, based on public strategy statements and the structure of the business, include the following.

• Higher-value seed mix. Better germplasm and new trait packages can lift both volume and pricing, especially in corn and soybeans.
• Further penetration of the Enlist system. System-based offerings can support seed sales, chemistry sales, and customer retention simultaneously.
• Crop protection innovation launches. Newer differentiated actives and formulations can offset generic pressure and improve margin mix.
• Scaling biologicals. Biologicals are one of Corteva’s clearest strategic growth vectors because they can be sold alongside conventional products and fit changing customer preferences.
• International expansion. Latin America and selected other regions can provide growth, although often with more currency, channel, and regulatory volatility.
• Licensing and partnerships. Monetizing traits, technology platforms, and external collaborations can broaden the earnings base.
• Digital agronomy. Digital tools can deepen customer relationships, improve recommendations, and make the commercial model more productive even if software is not the core revenue engine.

The main constraints are also clear: weather and acreage variability, farm economics, regulatory delays, competitive trait and chemistry launches, resistance management, generic crop protection competition, and the need to execute seasonal supply chains reliably.

14. What Is the History of Corteva?

Corteva became an independent company on June 1, 2019, when DowDuPont separated its agriculture business. But the company’s roots are much older. Its seed heritage includes Pioneer Hi-Bred, founded in 1926 by Henry A. Wallace and other investors, while its crop protection base includes legacy Dow and DuPont agricultural businesses built over decades.

Two historical milestones shaped today’s company. First, DuPont’s acquisition of Pioneer in 1999 helped create one of the strongest branded seed platforms in global agriculture. Second, the 2017 merger of Dow and DuPont created DowDuPont, which then separated into three independent companies, including Corteva. Since becoming independent, Corteva has focused on operating as a pure-play agriculture company and has used targeted acquisitions, especially in biologicals, to sharpen that positioning.

15. What Are the Key Suppliers to Corteva?

Suppliers matter strategically to Corteva because both seed and crop protection are time-sensitive businesses with strict quality requirements.

• Chemical raw material and intermediate suppliers. Crop protection economics depend on reliable access to active ingredient intermediates, solvents, surfactants, packaging, and formulation inputs.
• Contract manufacturing and tolling partners. These can be important for certain crop protection products where flexible capacity matters.
• Seed production growers and processing partners. In seeds, contract production and specialized seed-conditioning activities are essential to supply reliability.
• Biological input and fermentation-related suppliers. These matter more as Corteva expands biologicals.
• Logistics providers. Transportation and warehousing are strategically important because the value of an agricultural input can collapse if it misses the seasonal delivery window.

Corteva does not broadly disclose named suppliers in the way some manufacturing companies do, so the more useful lens is supplier category structure rather than individual vendor identity. Multi-sourcing, quality control, and seasonal execution matter more than dependence on one famous supplier brand.

16. What Are the Key Brands Owned by Corteva?

Branding is an important strategic lever for Corteva, especially in seeds.

• Pioneer. Corteva’s flagship premium seed brand. It is associated with deep agronomic support, performance positioning, and a more relationship-intensive selling model.
• Brevant. A seed brand designed to fit more naturally into retail channels. It gives Corteva a second route to market without diluting Pioneer’s positioning.
• Enlist. More than a single product brand, Enlist is a branded crop system that links seed traits and herbicide compatibility. That system positioning increases its strategic importance.
• Stoller. A meaningful brand in plant nutrition and biological solutions, added to strengthen Corteva’s biologicals platform.
• Symborg. A biologicals platform associated with microbiological solutions and innovation capabilities.

In crop protection, molecule and product brands matter, but Corteva’s long-term brand strength is most visible in the seed business and in system-based platforms that tie agronomic outcomes to the company’s broader portfolio.

17. How Does the Supply Chain of Corteva Function?

Corteva’s supply chain is strategically important because it must align scientific lead times, agricultural seasonality, and global distribution.

Seed supply chain

The seed supply chain is multi-season and biologically complex. It involves breeding and trait advancement, parent seed multiplication, grower production, harvest, conditioning, treatment, packaging, and shipment ahead of planting season. Forecasting errors can be costly because overproduction ties up working capital while underproduction can mean lost share for an entire season.

Crop protection supply chain

The crop protection supply chain involves sourcing raw materials and intermediates, manufacturing or formulating products, holding regional inventory, and delivering through distributors and retailers in time for application windows. Reliability, regulatory compliance, and cost control all matter, but so does flexibility because weather and pest pressure can shift demand rapidly.

Why it matters strategically

Supply-chain excellence is not just an operational hygiene factor for Corteva. It directly affects revenue capture, pricing, customer trust, and working capital. In a seasonal agricultural-input company, supply-chain failure can damage both the current season and the next year’s commercial relationship.

18. What Are the Key Assets of Corteva?

Corteva’s most important assets are a mix of intellectual property, biological assets, regulatory rights, brands, and physical infrastructure.

• Germplasm and breeding data. These are foundational assets in the seed business and a major barrier to entry.
• Trait technologies and associated intellectual property. Traits can create pricing power, licensing opportunities, and system-level customer lock-in.
• Crop protection molecules, patents, and registrations. Regulatory approvals and proprietary active ingredients are critical strategic assets.
• Biologicals know-how and product platforms. These became more important after the Stoller and Symborg additions.
• Seed production, conditioning, and manufacturing infrastructure. Physical assets matter because seasonal reliability is essential.
• Commercial relationships and brands. Pioneer in particular is a major commercial asset, not just a marketing label.

Corteva is asset-intensive in a broader sense than a pure industrial manufacturer. Returns depend on factories and working capital, but also on hard-to-replicate scientific, regulatory, and brand assets that compound over long product cycles.

19. What Is the Technology Strategy of Corteva?

Technology is central to Corteva’s competitiveness, both as an internal enabler and as part of the customer offering. Internally, the company relies on breeding technologies, genomics, data analytics, digital phenotyping, formulation science, and product-development systems to improve the speed and quality of innovation. Externally, it uses digital agriculture and agronomic decision tools to support growers and strengthen the commercial franchise.

One important feature of Corteva’s technology strategy is that it does not appear to treat digital as a separate story from the core business. Instead, digital tools are used to make the seed and crop protection portfolio more effective. That includes better agronomic recommendations, stronger customer insight, and improved commercial execution. The company’s Granular assets are relevant here, but the larger strategic point is that technology supports scientific differentiation and customer intimacy at the same time.

20. What Is the R&D Strategy of Corteva?

R&D is one of Corteva’s defining strategic strengths. The company competes in markets where new seed genetics, trait packages, active ingredients, and biological solutions can take years to develop and require major testing and regulatory work. That makes sustained R&D investment a core requirement, not a discretionary option.

Corteva’s R&D strategy appears to balance several horizons at once: near-term product improvement in seeds and formulations; medium-term trait and chemistry launches; and longer-cycle innovation in biologicals, new modes of action, and next-generation productivity platforms. The company also appears to use external collaborations where they accelerate capability building, but the center of gravity remains internal scientific capability and commercialization discipline.

For investors and strategy teams, the most important point is that R&D at Corteva is tightly linked to the business model. Better innovation not only creates new products; it also improves mix, pricing power, trait licensing opportunities, and the durability of customer relationships.

21. What Is the Finance Strategy of Corteva?

Corteva’s finance strategy is best understood as balanced capital allocation in a cyclical but innovation-driven industry. Management has publicly emphasized funding internal innovation and core operations first, then using targeted acquisitions to add capabilities, and also returning cash to shareholders through a dividend and share repurchases.

Working capital is a major part of the finance story because the company must carry seasonal inventories and manage receivables through the crop cycle. That means cash conversion can move around intra-year even when the underlying business is sound. Margin management is therefore closely linked to inventory discipline, manufacturing efficiency, pricing realization, and product mix.

At a high level, the finance strategy supports the broader corporate strategy by preserving flexibility. Corteva needs enough balance-sheet strength to keep investing through agricultural cycles, protect the R&D engine, and act selectively on capability-building deals such as those in biologicals.

22. What Major Acquisitions Has Corteva Made?

As an independent company, Corteva has used acquisitions selectively rather than as a serial roll-up strategy. The most important recent deals have been capability-building acquisitions in biologicals.

• Stoller. Announced in 2022 and closed in 2023, Stoller expanded Corteva’s position in biologicals and plant health, giving it more products and a stronger commercial base in that category.
• Symborg. Also announced in 2022 and closed in 2023, Symborg added microbiological technologies and strengthened Corteva’s biologicals innovation capabilities.

Corteva’s deal behavior suggests that M&A is primarily a tool for filling capability gaps and accelerating strategic adjacencies rather than for buying scale in the core business. Historically, predecessor-company deals also shaped today’s portfolio. For example, DuPont’s acquisition of Pioneer in 1999 and its acquisition of Granular in 2017 remain important to the assets now housed inside Corteva, but those were not executed by independent Corteva itself.

23. How Companies Like Corteva Leverage Independent Consultants through Umbrex

Umbrex has built a global community of more than 8,000 independent management consultants based in more than 50 countries. These consultants are alumni of McKinsey, Bain, BCG, and other top firms. Companies like Corteva use Umbrex when they need highly trained strategy, operations, technology, finance, or transformation talent without hiring a full consulting team and all of its overhead. For a science-based, globally distributed company like Corteva, the most relevant projects are usually those that sit at the intersection of innovation, commercialization, operations, and capital productivity.

• Seed portfolio and pricing optimization by crop, trait package, and channel, including Pioneer versus Brevant role clarity.
• Biologicals growth strategy, including integration of Stoller and Symborg capabilities into a coherent go-to-market model.
• Crop protection portfolio prioritization and launch planning for differentiated new products across regions.
• Sales model redesign for direct, retail, and distributor channels, including incentive design and account coverage.
• Seasonal supply-chain and inventory optimization for seed production, crop protection manufacturing, and regional deployment.
• Working-capital improvement programs focused on forecasting, receivables, inventory turns, and sales-and-operations planning.
• R&D portfolio stage-gate review, commercialization planning, and innovation governance for seeds, chemistry, and biologicals.
• Digital and AI use-case design for breeding analytics, demand forecasting, agronomic recommendations, and commercial decision support.
• Post-merger integration management office support for bolt-on acquisitions, partnerships, and new platform businesses.
• International growth strategy for Latin America and other priority markets, including channel strategy, pricing architecture, and market-entry economics.